Criteria for in vitro susceptibility testing of cefotetan. Correlations with clinical and bacteriologic responses (Q68142419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Criteria for in vitro susceptibility testing of cefotetan. Correlations with clinical and bacteriologic responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

0 references

0 references

1

A L Barry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

English

0 references

publication date

1 May 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Surgery

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

5A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

24-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Stability of cefotetan to Gram-negative beta-lactamases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Cefotetan: profile of in-vitro activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

In-vitro antibacterial activity of cefotetan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

In vitro susceptibility of the Bacteroides fragilis group in community hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Activity of cefotetan against anaerobic bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

The comparative in-vitro activity of cefotetan against anaerobic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Inhibitory activity of cefotetan and other beta-lactams against anaerobes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Cefotetan pharmacokinetics in volunteers with various degrees of renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Aerobically incubated thioglycolate broth disk method for antibiotic susceptibility testing of anaerobes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980208-3

10.1016/S0002-9610(88)80208-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3287965%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference